DNA topoisomerase II-alpha in pulmonary carcinoid tumors

Pathology Research and Practice

Volumn 197, Issue 3, 2001, Pages 169-173

  Resl M ^a   Simek J ^a   Bukac J ^a   Rothrockel P ^a   Siller J ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Atypical pulmonary carcinoid; Ki 67; Pulmonary carcinoid; Topoisomerase; Tumorlet

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); PARAFFIN; TUMOR MARKER;

ARTICLE; CARCINOID; CELL NUCLEUS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; LYMPH NODE METASTASIS; TUMOR CELL; TUMOR CLASSIFICATION; TUMOR VOLUME;

EID: 0035065986     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1078/0344-0338-00029     Document Type: Article

References (23)

1. Atypical carcinoid tumors of the lung
2. Mitosis counting in tumors
3. Proliferation-associated nuclear antigen Ki-S1 is identical with topoisomerase II alpha. Delineation of a carboxyterminal epitope with peptide antibodies
4. Prognostic relevance of histologic grading, the cell cycle-associated antigen Ki-S1 and cell cycle regulators in malignant fibrous histiocytomas: A multivariate analysis
5. Typical and Atypical Bronchopulmonary Carcinoid Tumors: A clinicopathologic and Ki-67-labeling study
6. Immunohistochemical detection of DNA topoisomerase type II alpha and KI-67 in adenoid cystic carcinoma and pleomorphic adenoma of the salivary gland
7. DNA topoisomerase II-alpha as a proliferation marker in astrocytic neoplasms of the central nervous system: Correlation with MIB1 expression and patient survival
8. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction
9. Ki-67 labeling indices in non-small cell lung cancer: Comparison between image cytometry and flow cytometry
10. A new proliferation-associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-S1
11. The impact of mitotic index on predicting outcome in breast carcinoma: A comparison of different counting methods in patient with different lymph node status
12. Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle in NIH 3T3 fibroblasts and L1210 leukemia cells
13. Prognostic significance of Ki-67 immunostaining and symptoms in resected stage I and II non-small cell lung cancer
14. An evaluation of the cell cycle-associated monoclonal antibody Ki-S1 as a prognostic factor in primary invasive adenocarcinoma of the breast
15. Proliferate activity in pulmonary carcinoids (in Czech)
16. Isolation and characterization of monoclonal antibodies to a recombinant human topoisomerase II polypeptide
17. Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. A multivariate study
18. Correlation between mitotic and Ki-67 labeling indices in paraffin-embedded carcinoma specimens
19. Expression of mitoses per thousand cells and cell density in breast carcinomas: A proposal
20. Expression of DNA topoisomerase I and DNA topoisomerase II-alpha in carcinoma of the colon
21. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid